BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8645034)

  • 41. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer.
    Medl M; Peters-Engl C; Schütz P; Vesely M; Sevelda P
    Anticancer Res; 2000; 20(2B):1133-4. PubMed ID: 10810409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mechanism of metastasis in cervical cancer].
    Kodama J; Hiramatsu Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():78-81. PubMed ID: 15535210
    [No Abstract]   [Full Text] [Related]  

  • 44. Metastatic adenocarcinoma of the lymph node: peculiar desmoplasia mimicking intravenous metastasis.
    Tanaka Y; Hirokawa M; Wakatsuki S; Sano T
    Histopathology; 2002 Dec; 41(6):566-7. PubMed ID: 12460214
    [No Abstract]   [Full Text] [Related]  

  • 45. [Influence of the selected pyrimidine compounds on the activity of thymidine phosphorylase from normal and tumor endometrial cells].
    Miszczak-Zaborska E; Smolarek M; Dramiński M; Kubiak R; Józwiak B; Bartkowiak J
    Ginekol Pol; 2009 Aug; 80(8):590-5. PubMed ID: 19824457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzymatic basis for the accumulation of Lewis(b) antigen in uterine endometrial cancer.
    Kubushiro K; Tsukazaki K; Sakuma Y; Sakayori M; Yazawa S; Nozawa S
    Jpn J Cancer Res; 1995 Apr; 86(4):361-7. PubMed ID: 7775258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Thymidine phosphorylase as a prognostic factors of breast cancers].
    Takahashi H; Todo S
    Nihon Rinsho; 2000 Apr; 58 Suppl():454-9. PubMed ID: 11026033
    [No Abstract]   [Full Text] [Related]  

  • 48. Routine use of extended field irradiation in early stage, poor prognosis endometrial and cervical carcinoma.
    Kadar N
    Gynecol Oncol; 1992 Nov; 47(2):276-7. PubMed ID: 1468708
    [No Abstract]   [Full Text] [Related]  

  • 49. [Route of lymphatic diffusion in carcinomas of the uterine cervix].
    PAPADIA S
    Minerva Ginecol; 1957 Aug; 9(16):679-86. PubMed ID: 13503831
    [No Abstract]   [Full Text] [Related]  

  • 50. Simple clefts, complex problems: reflections on glandular lesions of the uterine cervix.
    McCluggage WG
    Int J Gynecol Pathol; 2003 Jan; 22(1):103-4. PubMed ID: 12496709
    [No Abstract]   [Full Text] [Related]  

  • 51. [Recent advances in cervical and endometrial carcinoma and application of new techniques].
    Hui P
    Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):389-90. PubMed ID: 12675059
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunohistochemistry in pelvic nodes of patients with cervical cancer.
    Thornton JG; O'Donovan PO; Lunny D; Wells M; Pell KR
    Br J Obstet Gynaecol; 1992 Dec; 99(12):1029. PubMed ID: 1477010
    [No Abstract]   [Full Text] [Related]  

  • 53. Population differences in antigenic modulation of amylase on neoplastic transformation in the human endocervix.
    Griffin NR; Wells M; Fox H
    J Pathol; 1989 Feb; 157(2):153-4. PubMed ID: 2466113
    [No Abstract]   [Full Text] [Related]  

  • 54. The cytosol activity of thymidine phosphorylase in endometrial cancer.
    Miszczak-Zaborska E; Kubiak R; Bieńkiewicz A; Bartkowiak J
    J Exp Clin Cancer Res; 2008 Nov; 27(1):64. PubMed ID: 18986516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunohistochemistry and activities of thymidine phosphorylase in the tissues of uterine cervical and endometrial carcinomas].
    Kamoi S; Kawamoto M; Ohta Y; Takahashi H; Araki T
    Gan To Kagaku Ryoho; 1996 May; 23(6):801-4. PubMed ID: 8645034
    [No Abstract]   [Full Text] [Related]  

  • 56. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
    Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
    Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sentinel lymph node biopsy in cervical and endometrial cancers: a feasibility study].
    Lelièvre L; Camatte S; Le Frère-Belda MA; Kerrou K; Froissart M; Taurelle R; Vildé F; Lécuru F
    Bull Cancer; 2004 Apr; 91(4):379-84. PubMed ID: 15242323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frozen section examination of pelvic lymph nodes in endometrial and cervical cancer: accuracy in patients submitted to neoadjuvant treatments.
    Fanfani F; Ludovisi M; Zannoni GF; Distefano M; Fagotti A; Ceccaroni M; Mancuso S; Scambia G
    Gynecol Oncol; 2004 Sep; 94(3):779-84. PubMed ID: 15350373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The sentinel node in gynaecological malignancies.
    Balega J; Van Trappen PO
    Cancer Imaging; 2006 Feb; 6(1):7-15. PubMed ID: 16520291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thymidine phosphorylase activity in normal, hyperplastic and neoplastic endometrium--correlation with intratumoral angiogenesis.
    Sivridis E
    Adv Exp Med Biol; 2000; 476():297-303. PubMed ID: 10949674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.